Hansen et al. found that MTAP-deficient GBM patients overexpressed MTA binding to A2B receptor, which functions downstream of ARs like STAT3, inducing upregulation of ARG-1 and IL-10, the markers of M2 TAMs (Figure 3). This evidence concerns the gene MTAP and glioblastoma.